Enthusiasm for it in the UK as a weight management tool has risen after a University College London study, published in The New England Journal of Medicine , found a found a third of people who took it for obesity lost more than one-fifth of their total body weight
Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: A Cochrane meta-analysis
Clinical studies have shown that GLP-1 medications carry a small risk of pancreatitis
Zhang Q, Delessa CT, Augustin R, Bakhti M, Colldn G, Drucker DJ, et al
It is commonly available as a once-weekly injection
Ingredients appear in descending order by concentration